Performance stock grant to Thermo Fisher (NYSE: TMO) COO Lagarde

Rhea-AI Filing Summary

Thermo Fisher Scientific Executive Vice President & COO Michel Lagarde acquired 2,231 shares of common stock through a performance-based restricted stock unit award. The award was originally granted on February 19, 2025, and the Compensation Committee certified achievement of the performance criteria on February 25, 2026.

The award vests in three equal tranches on February 28, 2026, 2027 and 2028, subject to the terms of the award agreement. Following this grant, Lagarde directly owns 86,347.909 shares of Thermo Fisher Scientific common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lagarde Michel

Role Executive Vice President & COO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,231	$0.00	--

Holdings After Transaction: Common Stock — 86,347.909 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lagarde Michel

(Last) (First) (Middle)

168 THIRD AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President & COO

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		A		2,231(1)	A	$0	86,347.909	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares represent a performance-based restricted stock unit award granted on February 19, 2025. On February 25, 2026, the Compensation Committee certified achievement of the applicable performance criteria. The award vests in three equal tranches on February 28, 2026, 2027 and 2028, in accordance with the terms of the award agreement.

	/s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Thermo Fisher (TMO) insider Michel Lagarde report on this Form 4?

Michel Lagarde reported acquiring 2,231 shares of Thermo Fisher common stock via a performance-based restricted stock unit award. The transaction reflects equity compensation rather than an open-market purchase, increasing his directly owned stake in the company’s common stock.

How many Thermo Fisher (TMO) shares did Michel Lagarde acquire in this grant?

Michel Lagarde acquired 2,231 shares tied to a performance-based restricted stock unit award. These shares were credited after performance criteria were certified, representing an equity incentive rather than a cash transaction, and add to his existing Thermo Fisher common stock holdings.

When were Michel Lagarde’s Thermo Fisher (TMO) performance goals certified for this award?

The Compensation Committee certified achievement of the applicable performance criteria on February 25, 2026. This certification triggered the recognition of 2,231 performance-based restricted stock units that had been granted earlier, allowing them to vest over the following three-year schedule.

What is the vesting schedule for Michel Lagarde’s Thermo Fisher (TMO) RSU award?

The performance-based restricted stock unit award vests in three equal tranches on February 28, 2026, 2027 and 2028. This structure spreads the delivery of the 2,231 underlying shares over three years, aligning ongoing equity compensation with sustained service and prior performance.

How many Thermo Fisher (TMO) shares does Michel Lagarde own after this Form 4 transaction?

After this transaction, Michel Lagarde directly owns 86,347.909 shares of Thermo Fisher common stock. This total includes the newly credited 2,231 shares from the performance-based restricted stock unit award, as reported in the Form 4 ownership table.

Was Michel Lagarde’s Thermo Fisher (TMO) share award an open-market purchase?

No, the reported 2,231 shares came from a performance-based restricted stock unit award rather than an open-market purchase. The grant carried a stated price of $0.0000 per share and was tied to pre-set performance criteria certified by the Compensation Committee.